已收盤 08-08 16:00:00 美东时间
+0.210
+3.18%
今日重点评级关注:韦德布什:维持Gossamer Bio"跑赢大市"评级,目标价从4美元升至5美元;HC Wainwright & Co.:维持EyePoint Pharmaceuticals"买入"评级,目标价从22美元升至23美元
08-07 09:46
Keybanc analyst Scott Schoenhaus maintains LifeMD (NASDAQ:LFMD) with a Overweight and lowers the price target from $14 to $12.
08-06 21:51
Shares of Astera Labs, Inc. (NASDAQ:ALAB) rose sharply in pre-market trading af...
08-06 17:35
Gainers BiomX (AMEX:PHGE) shares moved upwards by 40.1% to $0.61 during Tuesda...
08-06 05:07
LifeMD (NASDAQ:LFMD) affirms FY2025 sales outlook from $268.000 million-$275.000 million to $268.000 million-$275.000 million vs $270.357 million estimate.
08-06 04:08
康普单日飙涨86%!获安费诺收购宽带业务;法拉第未来隔夜涨近20%,新车型FX Super One进入试产阶段>>
08-05 17:07
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
U.S. stocks were higher, with the Dow Jones index gaining around 400 points on ...
08-04 23:55
LifeMD, Inc. (Nasdaq: LFMD), a leading virtual primary care provider, announced its participation in the Canaccord Genuity 45th Annual Growth Conference, to be held August 12-14, 2025 in Boston. Management will host a fireside chat on August 13 at 8:30 a.m. ET and conduct investor meetings on August 12-13. Investors can register through their Canaccord Genuity representative. LifeMD offers telemedicine, lab, and pharmacy services for over 200 con...
08-04 12:00
LifeMD ( ($LFMD) ) has issued an announcement. On July 31, 2025, LifeMD announc...
08-01 05:15